Table 2.
Changes in Quality-of-life and Arthritis-related Questionnaires From Baseline to 12 Weeks Among 4 Participants With Possible RA
| Questionnaire | Baseline | Week 2 | Week 4 | Week 8 | Week 12 |
|---|---|---|---|---|---|
| VAS-P | 5.23 ± 0.66 | 3.93 ± 0.41 | 2.40 ± 0.75 | 1.08 ± 0.63 | 0.90 ± 0.52 |
| MSQ joint/muscle | 11.25 ± 2.29 | 8.25 ± 2.59 | 10.00 ± 1.78 | 8.75 ± 2.59 | 7.25 ± 2.25 |
| MSQ total | 28.50 ± 7.59 | 21.75 ± 8.81 | 20.50 ± 5.33 | 21.75 ± 6.54 | 21.75 ± 10.13 |
| MOS-SF36 physical | 25.60 ± 2.84 | 26.23 ± 4.20 | 29.90 ± 2.30 | 34.63 ± 6.56 | 36.48 ± 2.52 |
| MOS-SF36 mental | 54.03 ± 6.26 | 59.30 ± 5.66 | 58.20 ± 4.84 | 55.35 ± 2.91 | 60.10 ± 1.95 |
| AIQ arthritis symptoms | 13.25 ± 1.11 | 13.75 ± 1.44 | 15.50 ± 1.32 | 18.50 ± 2.40 | 20.00 ± 1.47 |
| AIQ daily living | 27.65 ± 5.40 | 18.25 ± 2.06 | 18.05 ± 3.66 | 10.10 ± 3.44 | 8.33 ± 4.03 |
| HAQ-DI Q26 | 61.25 ± 10.87 | 45.00 ± 3.54 | 38.00 ± 6.31 | 22.50 ± 10.31 | 15.75 ± 3.61 |
| AIMS2 | 6.00 ± 0.54 | 5.00 ± 0.20 | 4.88 ± 0.43 | 3.13 ± 0.77 | 2.25 ± 0.60 |
Note: Data are mean ± SE. No statistical analysis was performed.
Abbreviations: RA, rheumatoid arthritis; SE, standard error of the mean; VAS-P, visual analog scale for pain; MSQ, medical symptoms questionnaire; MOS-SF36, health and wellness outcome questionnaire; AIQ, arthritis impact questionnaire; HAQ-DI Q26, health assessment questionnaire question 26; AIMS2, arthritis impact measurement scales 2.